Solvias announced the acquisition of Confarma, headquartered in Münchenstein, and its subsidiary Confarma France.
Solvias, a pharmaceutical service provider, is pursuing a long-term growth strategy with the aim of expanding its extensive range of services for pharmaceutical companies. By acquiring the Confarma Group, Solvias and Confarma are increasing the range of analytical services they can offer their partners in pharmaceuticals, biotechnology, and life science.
The EU Green Deal has hurt Europe's industry. The Clean Industrial Deal aims to improve this, but a change of mindset at the Commission is needed.
Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
Europe's chemical industry is in crisis, warns the European Chemical Industry Council (CEFIC) President Ilham Kadri, urging EU leaders to act on a 10-point rescue plan to prevent further shutdowns and loss of investments.
